Inactive Instrument
Tobira Therapeutics Inc Share Price
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| -1.56% | -2.95% | +21.03% | +75.97% | 58.81B | |
| -0.09% | +0.24% | +6.74% | +34.41% | 48.45B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 42.84B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 42.79B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.05B | |
| Average | -0.82% | -0.25% | +52.62% | +123.03% | 43.81B | |
| Weighted average by Cap. | -0.37% | -0.54% | +55.40% | +129.30% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
